STAT+: Pharmalittle: We’re reading about Wegovy insurance coverage, Zepbound shortages, and more
STAT
MARCH 29, 2024
health insurers have agreed to start paying for the Wegovy weight-loss drug for certain people on Medicare with heart conditions, The Wall Street Journal reports. From 2013 to 2022, pharmaceutical and device companies made more than 85 million payments totaling $12.1 Well, whatever you do, have a grand time. But be safe.
Let's personalize your content